Literature DB >> 30930348

Triglycerides as Residual Risk for Atherosclerotic Cardiovascular Disease.

Hirotoshi Ohmura1.   

Abstract

Entities:  

Year:  2019        PMID: 30930348     DOI: 10.1253/circj.CJ-19-0239

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  5 in total

Review 1.  Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.

Authors:  Bai-Hui Zhang; Fan Yin; Ya-Nan Qiao; Shou-Dong Guo
Journal:  Front Mol Biosci       Date:  2022-05-25

2.  Potassium selenocyanoacetate reduces the blood triacylglycerol and atherosclerotic plaques in high-fat-dieted mice.

Authors:  Shaoqin Liu; Fang Fang; Guanghui Fan
Journal:  Cardiovasc Diagn Ther       Date:  2019-12

3.  Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis.

Authors:  Ta-Liang Chen; Chien-Chang Liao; Li-Chin Sung; Chuen-Chau Chang; Chao-Shun Lin; Chun-Chieh Yeh; Yih-Giun Cherng
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

4.  Triglycerides as Biomarker for Predicting Systemic Lupus Erythematosus Related Kidney Injury of Negative Proteinuria.

Authors:  Mingjun Si; Danyang Li; Ting Liu; Yuanyan Cai; Jingyu Yang; Lili Jiang; Haitao Yu
Journal:  Biomolecules       Date:  2022-07-05

5.  The Risk of Fasting Triglycerides and its Related Indices for Ischemic Cardiovascular Diseases in Japanese Community Dwellers: the Suita Study.

Authors:  Aya Higashiyama; Ichiro Wakabayashi; Tomonori Okamura; Yoshihiro Kokubo; Makoto Watanabe; Misa Takegami; Kyoko Honda-Kohmo; Akira Okayama; Yoshihiro Miyamoto
Journal:  J Atheroscler Thromb       Date:  2021-05-28       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.